The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSmurfit Kappa Regulatory News (SKG)

Share Price Information for Smurfit Kappa (SKG)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 3,416.00
Bid: 3,416.00
Ask: 3,420.00
Change: -24.00 (-0.70%)
Spread: 4.00 (0.117%)
Open: 3,422.00
High: 3,448.00
Low: 3,402.00
Prev. Close: 3,440.00
SKG Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Form 8.3 - SMURFIT KAPPA GROUP PLC

22 May 2018 08:50

RNS Number : 8461O
Societe Generale SA
22 May 2018
 

Ap19

 

 

FORM 8.3

 

IRISH TAKEOVER PANEL

 

DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013

 

DEALINGS BY PERSONS WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE

 

1. KEY INFORMATION

 

Name of person dealing (Note 1)

Société Générale S.A.

Company dealt in

Smurfit Kappa Group Plc

Class of relevant security to which the dealings being disclosed relate (Note 2)

€0.001 ordinary shares

Date of dealing

21/05/2018

 

2. INTERESTS AND SHORT POSITIONS

 

(a) Interests and short positions (following dealing) in the class of relevant security dealt in (Note 3)

 

Long

Short

Number

(%)

Number

(%)

(1) Relevant securities

3,662,965

1.54

2,935

0.00

(2) Derivatives (other than options)

92,303

0.04

2,727,015

1.15

(3) Options and agreements to purchase/sell

0

0.00

0

0.00

Total

*6,771,749

*2.85

2,729,950

1.15

 

* Include the holding of 3,016,481 shares on borrow products

 

 

 

(b) Interests and short positions in relevant securities of the company, other than the class dealt in (Note 3)

 

Class of relevant security:

Long

Short

Number

(%)

Number

(%)

(1) Relevant securities

(2) Derivatives (other than options)

(3) Options and agreements to purchase/sell

Total

Ap20

 

1. DEALINGS (Note 4)

 

(a) Purchases and sales

 

 

 

Purchase/sale

 

Number of relevant securities

 

Price per unit GBP (Note 5)

Purchase

211

30

Purchase

460

30

Purchase

146

30.08

Purchase

58

30.06

Purchase

108

30.06

Purchase

146

30.1

Purchase

56

30

Purchase

222

30

Purchase

146

30.06

Purchase

268

30

Purchase

146

30.08

Purchase

146

30.1

Purchase

208

30.04

Purchase

103

30.04

Purchase

162

30.04

Purchase

219

30.04

Purchase

184

30

Purchase

80

30.04

Purchase

66

30.04

Purchase

34

30.02

Purchase

146

30.04

Purchase

112

30.02

Purchase

103

30.02

Purchase

43

30.02

Purchase

146

30

Purchase

178

30.06

Purchase

239

29.98

Purchase

178

29.96

Purchase

320

29.98

Purchase

40

29.94

Purchase

25

29.92

Purchase

150

29.94

Purchase

147

30.02

Purchase

159

29.94

Purchase

114

29.88

Purchase

75

30.06

Purchase

147

30

Purchase

71

30.06

Purchase

146

30

Purchase

146

30.12

Purchase

146

30.14

Purchase

146

30.02

Purchase

199

30

Purchase

150

30

Purchase

120

29.98

Purchase

24

29.98

Purchase

107

29.94

Purchase

150

30.02

Purchase

388

30.02

Purchase

75

30

Purchase

280

30

Purchase

160

30

Purchase

47

29.94

Purchase

53

30

Purchase

170

30

Purchase

129

30

Purchase

95

30

Purchase

200

30

Purchase

187

29.98

Purchase

150

29.98

Purchase

41

29.96

Purchase

459

29.96

Purchase

150

29.94

Purchase

106

29.94

Purchase

168

30

Purchase

500

29.96

Purchase

249

29.94

Purchase

107

29.94

Purchase

125

29.9

Purchase

170

29.96

Purchase

170

29.96

Purchase

125

29.96

 

Purchase/sale

 

Number of relevant securities

 

Price per unit EUR (Note 5)

Purchase

374

34.18

 

Purchase/sale

 

Number of relevant securities

 

Price per unit GBP (Note 5)

Sale

330

30

Sale

697

30

Sale

1,123

30

Sale

2,967

30

Sale

97

30

Sale

3,064

30

Sale

130

30.06

Sale

167

30.12

Sale

146

30.1

Sale

97

29.98

Sale

7

29.98

Sale

16

30.06

Sale

146

30.08

Sale

146

30.08

Sale

213

30.1

Sale

786

30.06

 

Purchase/sale

 

Number of relevant securities

 

Price per unit EUR (Note 5)

Sale

528

34.65306818

Total Purchases

11,574

Total Sales

10,660

 

(b) Derivatives transactions (other than options transactions)

 

 

Product name,

e.g. CFD

Nature of transaction

(Note 6)

Number of relevant securities

(Note 7)

Price per unit EUR (Note 5)

CFD

Reducing a short position

528

34.65306818

 

 

(c) Options transactions in respect of existing relevant securities

 

 

(i) Writing, selling, purchasing or varying

 

Product name,

e.g. call option

Writing, selling, purchasing, varying etc.

Number of securities to which the option relates (Note 7)

Exercise price

Type, e.g. American, European etc.

Expiry date

Option money paid/received per unit (Note 5)

 

 

(ii) Exercising

 

Product name,

e.g. call option

Number of securities

Exercise price per unit (Note 5)

 

(d) Other dealings (including transactions in respect of new securities) (Note 4)

 

Nature of transaction

(Note 8)

Details

Price per unit

(if applicable) (Note 5)

 

 

 

 

Ap21

 

2. OTHER INFORMATION

 

Agreements, arrangements or understandings relating to options or derivatives

 

 

 

 

Full details of any agreement, arrangement or understanding between the person disclosing and any other person relating to the voting rights of any relevant securities under any option referred to on this form or relating to the voting rights or future acquisition or disposal of any 

relevant securities to which any derivative referred to on this form is referenced. If none, 

this should be stated.

 

 

 

 

 

 

 

 

 

 

Is a Supplemental Form 8 attached? (Note 9)  NO

 

Date of disclosure

22/05/2018

Contact name

Société Générale - Disclosure team

Telephone number

+33 1 42 14 92 74

If a connected EFM, name of offeree/offeror with which connected

If a connected EFM, state nature of connection (Note 10)

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
ISESEASWEFASELI
Date   Source Headline
23rd Apr 20249:35 amRNSHolding(s) in Company
22nd Apr 20245:23 pmRNSHolding(s) in Company
22nd Apr 20245:18 pmRNSHolding(s) in Company
18th Apr 202410:29 amRNSHolding(s) in Company
17th Apr 20244:10 pmRNSHolding(s) in Company
17th Apr 202410:27 amRNSHolding(s) in Company
16th Apr 20245:22 pmRNSHolding(s) in Company
16th Apr 202412:34 pmRNSHolding(s) in Company
12th Apr 20249:45 amRNSHolding(s) in Company
11th Apr 20243:36 pmRNSHolding(s) in Company
11th Apr 202410:27 amRNSHolding(s) in Company
9th Apr 202410:21 amRNSHolding(s) in Company
8th Apr 202411:29 amRNSHolding(s) in Company
2nd Apr 20245:24 pmRNSHolding(s) in Company
2nd Apr 20245:17 pmRNSHolding(s) in Company
2nd Apr 202410:22 amRNSHolding(s) in Company
28th Mar 20245:08 pmRNSHolding(s) in Company
26th Mar 20245:05 pmRNSDirector/PDMR Shareholding
25th Mar 20242:28 pmRNSHolding(s) in Company
22nd Mar 20244:53 pmRNSHolding(s) in Company
22nd Mar 202410:46 amRNSHolding(s) in Company
21st Mar 20245:16 pmRNSHolding(s) in Company
19th Mar 20243:17 pmRNSHolding(s) in Company
19th Mar 202412:44 pmRNSHolding(s) in Company
19th Mar 202412:28 pmRNSHolding(s) in Company
15th Mar 20244:13 pmRNSDirector/PDMR Shareholding
15th Mar 20243:00 pmRNSPublication of Annual Report and Notice of AGM
15th Mar 20242:43 pmRNSHolding(s) in Company
13th Mar 202410:45 amRNSHolding(s) in Company
6th Mar 202410:34 amRNSHolding(s) in Company
1st Mar 20245:04 pmRNSHolding(s) in Company
29th Feb 20244:42 pmRNSTotal Voting Rights
26th Feb 20249:51 amRNSHolding(s) in Company
21st Feb 20245:16 pmRNSHolding(s) in Company
19th Feb 20249:35 amRNSBlock listing Interim Review
16th Feb 20245:05 pmRNSDirector/PDMR Shareholding
14th Feb 202412:08 pmRNSHolding(s) in Company
14th Feb 202411:08 amRNSHolding(s) in Company
13th Feb 202412:22 pmRNSHolding(s) in Company
6th Feb 20244:14 pmRNSHolding(s) in Company
6th Feb 202412:19 pmRNSHolding(s) in Company
2nd Feb 20245:13 pmRNSHolding(s) in Company
2nd Feb 202412:38 pmRNSHolding(s) in Company
1st Feb 20245:26 pmRNSHolding(s) in Company
30th Jan 20243:44 pmRNSHolding(s) in Company
30th Jan 20243:35 pmRNSHolding(s) in Company
11th Jan 20249:48 amRNSHolding(s) in Company
5th Jan 20244:42 pmRNSHolding(s) in Company
2nd Jan 20242:02 pmRNSHolding(s) in Company
2nd Jan 20247:00 amRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.